{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:20:35Z","timestamp":1776727235160,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ajog.2009.01.030","type":"journal-article","created":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T04:28:42Z","timestamp":1239942522000},"page":"489.e1-489.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection"],"prefix":"10.1016","volume":"200","author":[{"given":"Tiffany G.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini L.","family":"Kulasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy B.","family":"Kiviat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Koutsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2009.01.030_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2009.01.030_bib2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2009.01.030_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1054\/bjoc.2000.1523","article-title":"Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort","volume":"83","author":"Deacon","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.bjc.6600971","article-title":"Human papillomavirus infection and use of oral contraceptives","volume":"88","author":"Green","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Incident infection with genital human papillomavirus: rates and risk factors in a cohort of college women","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2009.01.030_bib6","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":"Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2009.01.030_bib7","first-page":"1129","article-title":"Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control","volume":"10","author":"Giuliano","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2009.01.030_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ijc.21279","article-title":"Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology","volume":"117","author":"Castle","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2009.01.030_bib10","first-page":"485","article-title":"Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen oral contraceptives (South Africa)","volume":"14","author":"Shapiro","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2009.01.030_bib11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","article-title":"Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral","volume":"288","author":"Kulasingam","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2009.01.030_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/aje\/kwh115","article-title":"Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia","volume":"159","author":"Harris","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2009.01.030_bib13","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ajog.2007.11.051","article-title":"Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States","volume":"199","author":"Baseman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.01.030_bib14","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JCM.36.10.3020-3027.1998","article-title":"Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method","volume":"36","author":"Gravitt","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajog.2009.01.030_bib15","first-page":"115","article-title":"The Bethesda System for reporting cervical\/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991","volume":"37","year":"1993","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ajog.2009.01.030_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2009.01.030_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<613::AID-IJC1>3.0.CO;2-T","article-title":"Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women","volume":"76","author":"Kruger-Kjaer","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/152460901300233911","article-title":"Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development","volume":"10","author":"Coker","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.ajog.2009.01.030_bib19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1054\/bjoc.2001.1779","article-title":"HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica","volume":"84","author":"Hildesheim","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2009.01.030_bib21","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2009.01.030_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0065-230X(01)82007-8","article-title":"Immunity to oncogenic human papillomaviruses","volume":"82","author":"Konya","year":"2001","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ajog.2009.01.030_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajog.2009.01.030_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.10868","article-title":"Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma","volume":"103","author":"de Villiers","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0002-9378(90)91323-5","article-title":"Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives","volume":"162","author":"Pater","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.01.030_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/07357909909011713","article-title":"Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone","volume":"17","author":"Yuan","year":"1999","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ajog.2009.01.030_bib27","first-page":"5","article-title":"Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones","volume":"81","author":"Mittal","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.01.030_bib28","first-page":"233","article-title":"Interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer","volume":"81","author":"von Knebel Doeberitz","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/j.ajog.2009.01.030_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1073\/pnas.88.4.1411","article-title":"Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells","volume":"88","author":"von Knebel Doeberitz","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2009.01.030_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1097-0142(19981225)84:6<328::AID-CNCR3>3.0.CO;2-Z","article-title":"Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate","volume":"84","author":"Valente","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2009.01.030_bib31","series-title":"Sexually transmitted diseases","article-title":"Cervical neoplasia and other STD-related genital tract neoplasias","author":"Kiviat","year":"1999"},{"key":"10.1016\/j.ajog.2009.01.030_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-0339(200009)23:3<161::AID-DC4>3.0.CO;2-O","article-title":"Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (Depo-Provera) for contraception","volume":"23","author":"Volk","year":"2000","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ajog.2009.01.030_bib33","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0002-9378(98)70151-6","article-title":"Colposcopic appearance of cervical intraepithelial neoplasia is age dependent","volume":"179","author":"Zahm","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.01.030_bib34","first-page":"431","article-title":"Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium","volume":"96","author":"Miller","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.01.030_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0010-7824(99)00058-X","article-title":"The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy","volume":"60","author":"Mauck","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2009.01.030_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0010-7824(99)00049-9","article-title":"Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera","volume":"59","author":"Kuhn","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2009.01.030_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-7824(00)00132-3","article-title":"The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera","volume":"62","author":"Bahamondes","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2009.01.030_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.aje.a116907","article-title":"Comparison of recalled and validated oral contraceptive histories","volume":"138","author":"Nischan","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2009.01.030_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2009.01.030_bib40","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780900088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780900088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:30:18Z","timestamp":1757586618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293780900088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S000293780900088X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2009.01.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2009.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}